Corrigendum to a cross-industry collaboration to assess if acute toxicity (Q)SAR models are fit-for-purpose for GHS classification and labelling. Regulatory toxicology and pharmacology (2021) 104843

Affiliations

• ¹ Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.
• ² Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
• ³ Ultragenyx, 60 Leveroni Court, Novato, CA, 94949, USA.
• ⁴ Bristol Myers Squibb, Drug Safety Evaluation, 1 Squibb Dr, New Brunswick, NJ, 08903, USA.
• ⁵ AbbVie Inc., North Chicago, IL, USA.
• ⁶ 3M Company, 3M Center, St. Paul, MN, 55144-1000, USA.
• ⁷ Syngenta Crop Protection, Product Safety Department, Jealott's Hill International Research Centre, Bracknell, Berkshire, RG42 6EY, UK.
• ⁸ DSM Nutritional Products, Kaiseraugst, Switzerland.
• ⁹ Galapagos SASU, 102 Avenue Gaston Roussel, 93230, Romainville, France.
• ¹⁰ GlaxoSmithKline, Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom.
• ¹¹ Janssen Pharmaceutical Companies of Johnson & Johnson, 2340, Beerse, Belgium.
• ¹² Vertex Pharmaceuticals Inc., Discovery and Investigative Toxicology, 50 Northern Ave, Boston, MA, USA.
• ¹³ Department of Veterinary Physiology and Pharmacology, Interdisciplinary Faculty of Toxicology Program, Texas A&M University, 4466 TAMU, College Station, TX, 77843-4466, USA.
• ¹⁴ Leadscope (an Instem Company), 1393 Dublin Rd, Columbus, OH, 43215, USA. Electronic address: glenn.myatt@instem.com.